Intravascular Ultrasound for Peripheral Artery Disease Revascularization (NCT06979284)
Intravascular Ultrasound for Peripheral Artery Disease Revascularization: The CLARITY Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greater than 50% re-narrowing of the treated artery) in adult patients who have CLTI and are undergoing percutaneous revascularization.
Who can join: Review the eligibility criteria below.
Location: Hamilton General Hospital — Hamilton
Age range: 18 Years
🧪 Interventions in This Study
- IVUS-guided strategy (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Hamilton General Hospital — Hamilton,
- Unity Health Toronto - St. Micheal's Hospital — Toronto,
📞 Contact the Study Coordinator
Phone: (905) 521-2100
Email: CLARITY@phri.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Arterial Disease(PAD)
Explore by condition: All Peripheral Arterial Disease(PAD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.